Sonic Healthcare Beheer

Beheer criteriumcontroles 4/4

De CEO Sonic Healthcare's is Colin Goldschmidt, benoemd in Jan1993, heeft een ambtstermijn van 31.75 jaar. De totale jaarlijkse vergoeding van { bedraagt A$ 5.97M, bestaande uit 39.7% salaris en 60.3% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.21% van de aandelen van het bedrijf, ter waarde A$ 26.81M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 27.8 jaar en 10 jaar.

Belangrijke informatie

Colin Goldschmidt

Algemeen directeur

AU$5.2m

Totale compensatie

Percentage CEO-salaris	45.9%
Dienstverband CEO	31.8yrs
Eigendom CEO	0.2%
Management gemiddelde ambtstermijn	27.8yrs
Gemiddelde ambtstermijn bestuur	10yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Colin Goldschmidt's beloning veranderd ten opzichte van Sonic Healthcare's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	AU$5m	AU$2m	AU$511m
Mar 31 2024	n/a	n/a	AU$508m
Dec 31 2023	n/a	n/a	AU$505m
Sep 30 2023	n/a	n/a	AU$595m
Jun 30 2023	AU$6m	AU$2m	AU$685m
Mar 31 2023	n/a	n/a	AU$850m
Dec 31 2022	n/a	n/a	AU$1b
Sep 30 2022	n/a	n/a	AU$1b
Jun 30 2022	AU$8m	AU$2m	AU$1b
Mar 31 2022	n/a	n/a	AU$1b
Dec 31 2021	n/a	n/a	AU$1b
Sep 30 2021	n/a	n/a	AU$1b
Jun 30 2021	AU$7m	AU$2m	AU$1b
Mar 31 2021	n/a	n/a	AU$1b
Dec 31 2020	n/a	n/a	AU$951m
Sep 30 2020	n/a	n/a	AU$739m
Jun 30 2020	AU$4m	AU$2m	AU$528m
Mar 31 2020	n/a	n/a	AU$554m
Dec 31 2019	n/a	n/a	AU$581m
Sep 30 2019	n/a	n/a	AU$565m
Jun 30 2019	AU$6m	AU$2m	AU$550m
Mar 31 2019	n/a	n/a	AU$510m
Dec 31 2018	n/a	n/a	AU$470m
Sep 30 2018	n/a	n/a	AU$473m
Jun 30 2018	AU$5m	AU$2m	AU$476m

Compensatie versus markt: De totale vergoeding ($USD 3.46M ) Colin } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de Australian markt ($USD 2.72M ).

Compensatie versus inkomsten: De vergoeding van Colin is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Colin Goldschmidt (70 yo)

31.8yrs

Tenure

AU$5,162,206

Compensatie

Dr. Colin Stephen Goldschmidt, M.B.B.Ch., F.R.C.P.A., F.A.I.C.D. serves as the Chief Executive Officer of Sonic Healthcare Limited since 1993 and has been its Managing Director since 1992. Dr. Goldschmidt...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Colin Goldschmidt	CEO, MD & Executive Director	31.8yrs	AU$5.16m	0.21% A$ 26.9m
Christopher Wilks	Finance Director	31.8yrs	AU$2.39m	0.13% A$ 17.0m
Peter Savage	Chief Business Officer	no data	geen gegevens	geen gegevens
Stephen Fairy	Global Chief Medical Officer	no data	geen gegevens	geen gegevens
David Byrne	Chief Executive Officer of Sonic Healthcare UK	no data	AU$1.07m	geen gegevens
Paul Alexander	Deputy CFO & Company Secretary	23.8yrs	AU$354.42k	geen gegevens
Julian Adler	Chief Executive Officer of Sonic Healthcare Australia - Radiology	4.3yrs	geen gegevens	geen gegevens

27.8yrs

Gemiddelde duur

65.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van SHL is doorgewinterd en ervaren (gemiddelde ambtstermijn van 27.8 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Colin Goldschmidt	CEO, MD & Executive Director	31.8yrs	AU$5.16m	0.21% A$ 26.9m
Christopher Wilks	Finance Director	34.8yrs	AU$2.39m	0.13% A$ 17.0m
Kathryn Spargo	Non-Executive Independent Director	14.3yrs	AU$276.15k	0.0054% A$ 705.6k
Christine Bennett	Independent Non-Executive Director	2.1yrs	AU$224.96k	0.0011% A$ 138.2k
Neville Mitchell	Independent Non-Executive Director	7.1yrs	AU$279.30k	0.0020% A$ 264.8k
Mark Compton	Independent Non-Executive Chairman	10yrs	AU$577.50k	0.0030% A$ 393.9k
Louis Panaccio	Non-Executive Independent Director	19.3yrs	AU$275.10k	0.0017% A$ 217.8k
Katharine Giles	Independent Non-Executive Director	2.1yrs	AU$210.00k	0.00052% A$ 67.8k
Suzanne Crowe	Non-Executive Independent Director	4.5yrs	AU$265.65k	0.0015% A$ 195.6k

10.0yrs

Gemiddelde duur

67.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van SHL zijn ervaren en ervaren (gemiddelde ambtstermijn van 10 jaar).

Sonic Healthcare Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

Sonic Healthcare Limited, Annual General Meeting, Nov 19, 2024

Finance Director recently sold AU$1.3m worth of stock

CEO, MD & Executive Director recently sold AU$9.9m worth of stock

Sonic Healthcare Limited Announces Board Changes

Sonic Healthcare Limited, Annual General Meeting, Nov 17, 2022

Sonic Healthcare Limited, Annual General Meeting, Nov 27, 2022

Recent updates

Full year 2024 earnings released: EPS: AU$1.07 (vs AU$1.46 in FY 2023)

Sonic Healthcare Limited, Annual General Meeting, Nov 19, 2024

Final dividend of AU$0.63 announced

Sonic Healthcare Limited Declares Final Dividend for the Six Months Ended 30 June 2024, Payable on 19 September 2024

Full year 2024 earnings released: EPS: AU$1.07 (vs AU$1.46 in FY 2023)

Sonic Healthcare Limited to Report Fiscal Year 2024 Results on Aug 22, 2024

Sonic in the Running for Healius Imaging Business

New minor risk - Shareholder dilution

Upcoming dividend of AU$0.43 per share

First half dividend increased to AU$0.43

First half 2024 earnings released: EPS: AU$0.43 (vs AU$0.81 in 1H 2023)

Sonic Healthcare Limited to Report First Half, 2024 Results on Mar 20, 2024

Sonic Healthcare Limited (ASX:SHL) signed binding agreements to acquire Pathology Watch Inc. for $130 million.

Finance Director recently sold AU$1.3m worth of stock

Upcoming dividend of AU$0.62 per share at 3.2% yield

Sonic Healthcare Limited Announces Dividend for the Six Months Ended June 30, 2023, Payable on 21 September, 2023

Full year 2023 earnings released: EPS: AU$1.46 (vs AU$3.06 in FY 2022)

Sonic Healthcare Limited to Report Fiscal Year 2023 Results on Aug 17, 2023

Now 20% undervalued after recent price drop

Sonic Healthcare Limited (ASX:SHL) signed an binding agreement to acquire synlab Suisse SA from SYNLAB International GmbH for CHF 150 million.

Upcoming dividend of AU$0.42 per share at 3.1% yield

First half 2023 earnings released

Sonic Healthcare Limited Announces Dividend for the Six Months Ended December 31, 2022, Payable on March 22, 2023

Sonic Healthcare Limited to Report First Half, 2023 Results on Feb 16, 2023

CEO, MD & Executive Director recently sold AU$9.9m worth of stock

Sonic Healthcare Limited Announces Board Changes

Sonic Healthcare Limited, Annual General Meeting, Nov 17, 2022

Sonic Healthcare Limited, Annual General Meeting, Nov 27, 2022

Upcoming dividend of AU$0.60 per share

Full year 2022 earnings released: EPS: AU$3.06 (vs AU$2.76 in FY 2021)

Sonic Healthcare Limited Announces Dividend for the Six Months Ended June 30, 2022, Payable on 21 September, 2022

Insufficient new directors

Upcoming dividend of AU$0.40 per share

Sonic Healthcare Limited (ASX:SHL) announces an Equity Buyback for AUD 500 million worth of its shares.

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Sonic Healthcare Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on March 23, 2022

Sonic Healthcare Limited (ASX:SHL) acquired ProPath Laboratory, Inc.

Full year 2021 earnings released: EPS AU$2.76 (vs AU$1.11 in FY 2020)

CEO, MD & Executive Director recently sold AU$8.4m worth of stock

Upcoming dividend of AU$0.55 per share

Full year 2021 earnings released: EPS AU$2.76 (vs AU$1.11 in FY 2020)

Sonic Healthcare Limited (ASX:SHL) signed a binding agreement to acquire Canberra Imaging Group.

Rhythm Biosciences Adds Sonic Clinical Services to Colostat Clinical Trial

New 90-day low: AU$31.39

First half 2021 earnings released: EPS AU$1.42 (vs AU$0.54 in 1H 2020)

Revenue beats expectations

Sonic Healthcare Limited to Report First Half, 2021 Results on Feb 18, 2021

Sonic Healthcare Limited to Report Fiscal Year 2021 Results on Aug 18, 2021

Sonic Healthcare Limited Elects Professor Suzanne Crowe as A Director

Sonic Healthcare Limited Do Not Provide Earnings Guidance for the Fiscal Year 2021 Due to COVID-19

Earnings released

New 90-day high - AU$34.66

Sonic Healthcare Limited to Report Fiscal Year 2020 Results on Aug 20, 2020

New 90-day high - AU$33.38

New 90-day high - AU$31.60

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd